Nutra Pharma Corp (NPHC)

[HDOGTX]

NPHC The CEO said that a company with a Phase 2 drug should have a $100 million dollar market value according to studies. He said based on their pipeline they should have a $30 million market value right now. This according to his spring interview.

https://stockguru.com/nutra-pharma-ceo-rik-deitsch-interview/

This stock only has a market value of $2.4 million dollars right now based on my estimation of around 800 million shares outstanding and a .003 share price. NPHC is ridiculously undervalued at this level. The CEO said it should have a $30 million market value right now. That would put it around .04. Once phase 2 starts it should have a $100 million market value. That would put the share price at .13 per share based on 800 millions shares outstanding